JP2020535225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535225A5 JP2020535225A5 JP2020538758A JP2020538758A JP2020535225A5 JP 2020535225 A5 JP2020535225 A5 JP 2020535225A5 JP 2020538758 A JP2020538758 A JP 2020538758A JP 2020538758 A JP2020538758 A JP 2020538758A JP 2020535225 A5 JP2020535225 A5 JP 2020535225A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- cholestasis
- ceradelpal
- day
- pruritus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762563395P | 2017-09-26 | 2017-09-26 | |
| US62/563,395 | 2017-09-26 | ||
| PCT/US2018/052490 WO2019067373A1 (en) | 2017-09-26 | 2018-09-24 | TREATMENT OF CHOLESTATIC PRURIT |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535225A JP2020535225A (ja) | 2020-12-03 |
| JP2020535225A5 true JP2020535225A5 (enExample) | 2021-11-04 |
| JP7023371B2 JP7023371B2 (ja) | 2022-02-21 |
Family
ID=64564950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538758A Active JP7023371B2 (ja) | 2017-09-26 | 2018-09-24 | 胆汁うっ滞性そう痒の処置 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20190105291A1 (enExample) |
| EP (3) | EP3973959B8 (enExample) |
| JP (1) | JP7023371B2 (enExample) |
| KR (1) | KR102376794B1 (enExample) |
| CN (1) | CN111132675B (enExample) |
| AU (2) | AU2018342323B2 (enExample) |
| BR (1) | BR112020005074A2 (enExample) |
| CA (1) | CA3076614C (enExample) |
| CY (1) | CY1124894T1 (enExample) |
| DK (1) | DK3973959T3 (enExample) |
| ES (2) | ES2902349T3 (enExample) |
| FI (1) | FI3973959T3 (enExample) |
| HR (2) | HRP20212010T1 (enExample) |
| HU (2) | HUE070033T2 (enExample) |
| IL (2) | IL273569B (enExample) |
| LT (2) | LT3973959T (enExample) |
| MX (1) | MX392537B (enExample) |
| PL (2) | PL3687523T3 (enExample) |
| PT (2) | PT3687523T (enExample) |
| RS (1) | RS62790B1 (enExample) |
| SG (1) | SG11202002253SA (enExample) |
| SI (2) | SI3973959T1 (enExample) |
| SM (1) | SMT202200171T1 (enExample) |
| UA (1) | UA125600C2 (enExample) |
| WO (1) | WO2019067373A1 (enExample) |
| ZA (1) | ZA202001646B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3119384T3 (pl) | 2014-03-20 | 2019-03-29 | Cymabay Therapeutics, Inc. | Leczenie wewnątrzwątrobowych chorób cholestatycznych |
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| US12053445B2 (en) | 2016-03-31 | 2024-08-06 | Genfit | Methods of treatment of cholestatic diseases |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| AU2021220519A1 (en) * | 2020-02-10 | 2022-09-22 | Genfit | Treatment of primary biliary cholangitis with elafibranor |
| CN116490191A (zh) * | 2020-10-20 | 2023-07-25 | 葛兰素史克知识产权第二有限公司 | 治疗胆汁淤积性瘙痒的方法 |
| DK4225291T3 (da) | 2021-02-01 | 2024-05-27 | Cymabay Therapeutics Inc | Behandling af cholangiopati med seladelpar |
| KR20250139304A (ko) | 2023-01-29 | 2025-09-23 | 사이머베이 쎄라퓨틱스, 인코퍼레이티드 | 만성 소양증 피부병의 치료 |
| EP4654957A1 (en) | 2023-01-29 | 2025-12-03 | CymaBay Therapeutics, Inc. | Treatment of uremic pruritus |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1667964T3 (pl) | 2003-09-19 | 2010-01-29 | Janssen Pharmaceutica Nv | Kwasy 4-((fenoksyalkilo)tio)-fenoksyoctowe i analogi |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| PL3119384T3 (pl) * | 2014-03-20 | 2019-03-29 | Cymabay Therapeutics, Inc. | Leczenie wewnątrzwątrobowych chorób cholestatycznych |
| CN111093705A (zh) * | 2017-09-13 | 2020-05-01 | 诺华股份有限公司 | 包含fxr激动剂的组合 |
-
2018
- 2018-09-24 EP EP21201888.1A patent/EP3973959B8/en active Active
- 2018-09-24 BR BR112020005074-1A patent/BR112020005074A2/pt unknown
- 2018-09-24 SI SI201831200T patent/SI3973959T1/sl unknown
- 2018-09-24 CA CA3076614A patent/CA3076614C/en active Active
- 2018-09-24 HU HUE21201888A patent/HUE070033T2/hu unknown
- 2018-09-24 HR HRP20212010TT patent/HRP20212010T1/hr unknown
- 2018-09-24 DK DK21201888.1T patent/DK3973959T3/da active
- 2018-09-24 HR HRP20250022TT patent/HRP20250022T1/hr unknown
- 2018-09-24 LT LTEP21201888.1T patent/LT3973959T/lt unknown
- 2018-09-24 PL PL18811954T patent/PL3687523T3/pl unknown
- 2018-09-24 SG SG11202002253SA patent/SG11202002253SA/en unknown
- 2018-09-24 EP EP18811954.9A patent/EP3687523B1/en active Active
- 2018-09-24 PL PL21201888.1T patent/PL3973959T3/pl unknown
- 2018-09-24 PT PT188119549T patent/PT3687523T/pt unknown
- 2018-09-24 CN CN201880062348.XA patent/CN111132675B/zh active Active
- 2018-09-24 KR KR1020207011163A patent/KR102376794B1/ko active Active
- 2018-09-24 WO PCT/US2018/052490 patent/WO2019067373A1/en not_active Ceased
- 2018-09-24 EP EP24215203.1A patent/EP4523744A3/en active Pending
- 2018-09-24 MX MX2020007273A patent/MX392537B/es unknown
- 2018-09-24 LT LTEPPCT/US2018/052490T patent/LT3687523T/lt unknown
- 2018-09-24 UA UAA202001861A patent/UA125600C2/uk unknown
- 2018-09-24 ES ES18811954T patent/ES2902349T3/es active Active
- 2018-09-24 RS RS20211484A patent/RS62790B1/sr unknown
- 2018-09-24 AU AU2018342323A patent/AU2018342323B2/en active Active
- 2018-09-24 US US16/140,365 patent/US20190105291A1/en not_active Abandoned
- 2018-09-24 SI SI201830493T patent/SI3687523T1/sl unknown
- 2018-09-24 PT PT212018881T patent/PT3973959T/pt unknown
- 2018-09-24 JP JP2020538758A patent/JP7023371B2/ja active Active
- 2018-09-24 HU HUE18811954A patent/HUE057377T2/hu unknown
- 2018-09-24 ES ES21201888T patent/ES3012120T3/es active Active
- 2018-09-24 FI FIEP21201888.1T patent/FI3973959T3/fi active
- 2018-09-24 SM SM20220171T patent/SMT202200171T1/it unknown
-
2020
- 2020-03-16 ZA ZA2020/01646A patent/ZA202001646B/en unknown
- 2020-03-24 IL IL273569A patent/IL273569B/en unknown
- 2020-12-21 US US17/128,195 patent/US20210283078A1/en active Pending
-
2021
- 2021-10-22 AU AU2021254641A patent/AU2021254641B2/en active Active
- 2021-11-23 IL IL288340A patent/IL288340B2/en unknown
-
2022
- 2022-01-07 CY CY20221100017T patent/CY1124894T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020535225A5 (enExample) | ||
| FI3973959T3 (fi) | Kolestaattisen kutinan hoito seladelpaarilla | |
| JP2018030854A5 (enExample) | ||
| JP2018193377A5 (enExample) | ||
| JP2014511374A5 (enExample) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| JP2018529779A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2019518022A5 (enExample) | ||
| JP2017149726A5 (enExample) | ||
| JP2008512426A5 (enExample) | ||
| JP2018529742A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| JP2017014206A5 (enExample) | ||
| RU2015154037A (ru) | Применение антагониста рецептора NK-1 серлопитанта при зуде | |
| JP2012512164A5 (enExample) | ||
| JP2017505785A5 (enExample) | ||
| JP2016531885A5 (enExample) | ||
| JP2015522603A5 (enExample) | ||
| JP2017522300A5 (enExample) | ||
| JP2020111586A5 (enExample) | ||
| JP2019218379A5 (enExample) | ||
| JP2018505218A5 (enExample) | ||
| JP2020527138A5 (enExample) | ||
| JP2017514858A5 (enExample) |